Regulus prices public offering; Imprimis acquires anti-bleeding antibiotic candidate;

 @FierceBiotech: ICYMI yesterday: First successful transplant of retinas made from embryonic stem cells. Article | Follow @FierceBiotech

 @JohnCFierce: Report: Big Pharma mounts secret attack against data transparency rule (some companies will never learn). ICYMI yesterday | Follow @JohnCFierce

 @RyanMFierce: Biogen sees 'unlikely' link between Tecfidera and patient death. Story | Follow @RyanMFierce

> Regulus Therapeutics priced its public offering of 4.5 million shares of common stock at $9.50 per share. Release

> Quest PharmaTech has partnered with AD Biotech to share research and technology development resources. AD Biotech has provided $2 million of clinical development funding to Quest and has agreed to provide up to $10 million of additional funding in return for Quest common shares and future revenue sharing. Release

> Imprimis Pharmaceuticals ($IMMY) has acquired intellectual property for IPI-120, an antibiotic drug candidate to treat bleeding and clotting. Release

Medical Device News

 @FierceMedDev: Oxford University blood test designed to screen for stress. Item | Follow @FierceMedDev

 @MarkHFierce: Google is the lead in SynapDx's $15.4M funding round - the trial for its autism Dx blood test is now under way. ICYMI yesterday | Follow @MarkHFierce

 @DamianFierce: The FDA has changed its approach to medical device hackers, part of its new commitment to cybersecurity. Report | Follow @DamianFierce

> JenaValve lands $62.5M round for heart valve. More

> Baxter wins EU sign-off for $4B Gambro deal. News

> Medical devices help spur Israeli VC investment growth. Article

Pharma News

 @FiercePharma: Some good news for Forest Labs: Quarterly sales tick up 6% to almost $800M; Forest credits newer products. More | Follow @FiercePharma

 @CarlyHFierce: Former AstraZeneca exec Tony Zook officially in as new CEO of Vivus. News | Follow @CarlyHFierce

> China detains first U.S. citizen in pharma industry probe. Story

> GlaxoSmithKline forges ahead with hunt for Chinese vaccine partners. Article

> Biogen: Tecfidera link to MS patient's death 'unlikely.' Report

Biotech Research News

 @EmilyMFierce: Novartis MS drug prevents heart failure in animal study. Article | Follow @EmilyMFierce

> Retinas made from embryonic stem cells implanted into mice for the first time. News

> New 3-D model of diabetes target could shape drug design. Story

> Neural origins of menopausal hot flashes discovered. Item

> Revalesio drug alters Alzheimer's progression in animal model. Article

Pharma Manufacturing News

 @EricPFierce: Orphan drugs have become a key product for many companies. See why: Special report | Follow @EricPFierce

> Wockhardt FDA warning letter says QA staff tried to mislead inspectors. Report

> Drug shortages in Ireland getting worse. More

> New bill could free drug user fees from sequestration, improve oversight. Article

> Venus Remedies gets 9 Ukraine plants approved. Item

> AMRI gets issues under control at Burlington plant. Report

And Finally... A drug sold by Novartis ($NVS) to treat multiple sclerosis could potentially prevent heart failure. Story